Marin RetinaFeb 17, 20231 minNow Available: Syfovre for the Treatment of Geographic AtrophyFebruary 17, 2023 Apellis Pharmaceuticals, Inc. (Waltham, MA) today announced that the U.S. FDA has approved SYFOVRE™ (pegcetacoplan...
Marin RetinaJan 28, 20221 minFDA Approves Vabysmo to Treat Two Leading Causes of Vision LossJanuary 28, 2022 Genentech, a member of the Roche Group, today announced that the FDA has approved Vabysmo™ (faricimab-svoa) for the...
Marin RetinaSep 1, 20191 minPort Delivery Phase 2 LADDER AMD Study ResultsSeptember 1, 2019 Anti-VEGF therapy for exudative macular degeneration places a significant treatment burden both upon patients who must...
Marin RetinaNov 11, 20171 min7-year results from MUSTNovember 11, 2017 The MUST trial compared the effectiveness of systemic therapy vs. fluocinolone acetonide implant for severe uveitis. ...